[1]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=2524025 [NCBI, ExPASy, EBI, Israel, Japan]
Hampe A.,
Shamoon B.M.,
Gobet M.,
Sherr C.J.,
Galibert F.;
"Nucleotide sequence and structural organization of the human FMS proto-oncogene.";
Oncogene Res. 4:9-17(1989).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1038/320277a0; PubMed=2421165 [NCBI, ExPASy, EBI, Israel, Japan]
Coussens L.,
van Beveren C.,
Smith D.,
Chen E.,
Mitchell R.L.,
Isacke C.M.,
Verma I.M.,
Ullrich A.;
"Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.";
Nature 320:277-280(1986).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
TISSUE=Placenta;
DOI=10.1006/geno.1996.4482; PubMed=9027509 [NCBI, ExPASy, EBI, Israel, Japan]
Andre C.,
Hampe A.,
Lachaume P.,
Martin E.,
Wang X.P.,
Manus V.,
Hu W.X.,
Galibert F.;
"Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes.";
Genomics 39:216-226(1997).
|
[4]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16.
PubMed=2524648 [NCBI, ExPASy, EBI, Israel, Japan]
Visvader J.,
Verma I.M.;
"Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes.";
Mol. Cell. Biol. 9:1336-1341(1989).
|
[5]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16.
PubMed=3525854 [NCBI, ExPASy, EBI, Israel, Japan]
Wheeler E.F.,
Roussel M.F.,
Hampe A.,
Walker M.H.,
Fried V.A.,
Look A.T.,
Rettenmier C.W.,
Sherr C.J.;
"The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.";
J. Virol. 59:224-233(1986).
|
[6]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16.
TISSUE=Placenta;
Flick M.B.,
Sapi E.,
Kacinski B.M.;
"Expression of a novel exon in the 5' UTR of human c-fms transcripts.";
Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
|
[7]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 244-295.
DOI=10.1016/0092-8674(85)90099-6; PubMed=4028159 [NCBI, ExPASy, EBI, Israel, Japan]
Nienhuis A.W.,
Bunn H.F.,
Turner P.H.,
Gopal T.V.,
Nash W.G.,
O'Brien S.J.,
Sherr C.J.;
"Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q- syndrome.";
Cell 42:421-428(1985).
|
[8]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 874-972.
DOI=10.1073/pnas.83.20.7800; PubMed=3532121 [NCBI, ExPASy, EBI, Israel, Japan]
Browning P.J.,
Bunn H.F.,
Cline A.,
Shuman M.,
Nienhuis A.W.;
"'Replacement' of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential.";
Proc. Natl. Acad. Sci. U.S.A. 83:7800-7804(1986).
|
[9]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-302 AND ASN-353, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1021/pr0502065; PubMed=16335952 [NCBI, ExPASy, EBI, Israel, Japan]
Liu T.,
Qian W.-J.,
Gritsenko M.A.,
Camp D.G. II,
Monroe M.E.,
Moore R.J.,
Smith R.D.;
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.";
J. Proteome Res. 4:2070-2080(2005).
|
[10]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-555; TYR-556; THR-562 AND THR-567, AND MASS SPECTROMETRY.
DOI=10.2116/analsci.24.161; PubMed=18187866 [NCBI, ExPASy, EBI, Israel, Japan]
Imami K.,
Sugiyama N.,
Kyono Y.,
Tomita M.,
Ishihama Y.;
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Anal. Sci. 24:161-166(2008).
|
[11]
|
FUNCTION AS IL34 RECEPTOR.
DOI=10.1126/science.1154370; PubMed=18467591 [NCBI, ExPASy, EBI, Israel, Japan]
Lin H.,
Lee E.,
Hestir K.,
Leo C.,
Huang M.,
Bosch E.,
Halenbeck R.,
Wu G.,
Zhou A.,
Behrens D.,
Hollenbaugh D.,
Linnemann T.,
Qin M.,
Wong J.,
Chu K.,
Doberstein S.K.,
Williams L.T.;
"Discovery of a cytokine and its receptor by functional screening of the extracellular proteome.";
Science 320:807-811(2008).
|
[12]
|
VARIANTS [LARGE SCALE ANALYSIS] GLY-32; ARG-362; SER-413; VAL-536; HIS-693; ASP-920 AND GLN-921.
DOI=10.1038/nature05610; PubMed=17344846 [NCBI, ExPASy, EBI, Israel, Japan]
Greenman C.,
Stephens P.,
Smith R.,
Dalgliesh G.L.,
Hunter C.,
Bignell G.,
Davies H.,
Teague J.,
Butler A.,
Stevens C.,
Edkins S.,
O'Meara S.,
Vastrik I.,
Schmidt E.E.,
Avis T.,
Barthorpe S.,
Bhamra G.,
Buck G.,
Choudhury B., ![]()
Clements J.,
Cole J.,
Dicks E.,
Forbes S.,
Gray K.,
Halliday K.,
Harrison R.,
Hills K.,
Hinton J.,
Jenkinson A.,
Jones D.,
Menzies A.,
Mironenko T.,
Perry J.,
Raine K.,
Richardson D.,
Shepherd R.,
Small A.,
Tofts C.,
Varian J.,
Webb T.,
West S.,
Widaa S.,
Yates A.,
Cahill D.P.,
Louis D.N.,
Goldstraw P.,
Nicholson A.G.,
Brasseur F.,
Looijenga L.,
Weber B.L.,
Chiew Y.-E.,
DeFazio A.,
Greaves M.F.,
Green A.R.,
Campbell P.,
Birney E.,
Easton D.F.,
Chenevix-Trench G.,
Tan M.-H.,
Khoo S.K.,
Teh B.T.,
Yuen S.T.,
Leung S.Y.,
Wooster R.,
Futreal P.A.,
Stratton M.R.;
"Patterns of somatic mutation in human cancer genomes.";
Nature 446:153-158(2007).
|
|
ExPASy Home page
SIB Switzerland
